NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is an American biopharmaceutical company that specializes in the development, manufacturing, and commercialization of non-antibiotic anti-infective products. The company was founded in 2000 and is headquartered in Emeryville, California.

History

NovaBay Pharmaceuticals was established in the year 2000 with the aim of developing innovative therapies for the treatment of a wide range of infections without causing antibiotic resistance. The company's initial focus was on the development of products that mimic the action of the human immune system.

Products

NovaBay Pharmaceuticals has developed several products, including Avenova, a prescription product for the management of blepharitis and the associated bacterial skin infection. Avenova is the only commercial product that contains NovaBay's proprietary, pure hypochlorous acid.

Research and Development

NovaBay Pharmaceuticals' research and development efforts are focused on the company's proprietary, pure hypochlorous acid. The company's research team is working on developing new formulations and applications for this compound.

Financials

As a publicly traded company, NovaBay Pharmaceuticals' financial performance is subject to regular reporting. The company's stock is traded on the New York Stock Exchange under the ticker symbol "NBY".

See Also

• Biopharmaceutical
• Antibiotic resistance
• Blepharitis